Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
4
Neutral
6
Bullish
4
Bearish
34
Neutral
6
Bullish
6
Bearish
30
Neutral
0
Bullish
2
Investor Presentation
Q4 FY17
Investor Presentation
Q3 FY17
Investor Presentation
Q2 FY17
Investor Presentation
Q1 FY17
Investor Presentation
Q4 FY16
Investor Presentation
Q3 FY16

Market Cap
₹ 3,270 Cr
P/E
22.45
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
3,270 Cr
Moderate Risk
22.5
30.8
0.1
1.3
804.05
433.00
Sales CAGR
1Y
18.25%
3Y
22.56%
5Y
13.92%
10Y
3.84%
Profit CAGR
1Y
246.67%
3Y
—
5Y
—
10Y
5.52%
ROE
TTM
5.98%
3Y
-2.16%
5Y
-0.73%
10Y
11.57%
ROCE
TTM
6.30%
3Y
-0.60%
5Y
0.30%
10Y
-0.49%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK